TBTobias Bölling

Tobias Bölling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tobias Bölling has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2010
      • Vol. 30  (1) , 227-31

    Late effects of abdominal irradiation in children: a review of the literature.

    by Tobias Bölling, Normann Willich, Iris Ernst

    To comprehensively summarize the most important literature regarding the late effects of radiotherapy to the abdomen in childhood and adolescence. Published trials, studies and series were identified using the PubMed database. The key words late effects, late sequelae, child, radiation, radiotherapy, abdomen, kidney, liver, and bowel were used. A dose-volume effect is confirmed for liver irradiation. Radiation with doses <20 Gy to major parts of the liver or higher doses to smaller parts seems to be safe. Kidney function impairment due to radiation is rare in children. Renal sequelae may occur after radiation to the remaining kidney in patients who underwent nephrectomy or who received higher doses to both kidneys. Several reports describe small bowel obstruction as a sequelae of surgery, but radiotherapy seems to be less important. Several retrospective reports describe radiation-associated late sequelae in children. However, there is still a lack of sufficient data regarding the characterization of dose-volume effects.


  • Radiation Toxicity Following Busulfan/Melphalan High-dose Chemotherapy in the EURO-EWING-99-trial: Review of GPOH Data

    by Tobias Bölling, Uta Dirksen, Andreas Ranft, Iris Ernst, Heribert Jürgens, Normann Willich


    • 1 August 2009
      • Vol. 29  (8) , 3397-400

    Kidney-autotransplantation before radiotherapy: a case report.

    by Tobias Bölling, Kirsten Janke, Heiner H Wolters, Marco Glashörster, Iris Ernst, Normann Willich, Jens Brockmann, Stefan Könemann

    A 28-year-old man suffering from a Ewing tumour arising from the 9th-11th ribs with infiltration of neuroforamina without distant metastases was planned to receive radiotherapy following primary intralesional surgery and induction chemotherapy. Due to pleural infiltration and effusion, a hemithorax irradiation with a sequential boost to the primary tumour site had to be administered. Different treatment planning variants failed to provide sufficient radiotherapy planning in view of target volume coverage and avoidance of organs at risk, especially due to high calculated radiation doses potentially compromising the left kidney. To prevent left kidney organ exposure, an autotransplantation of the left kidney into the right fossa iliaca was performed. An infiltration of the kidney was initially excluded. Postoperatively, a renal scintigraphy showed a normal function of both kidneys allowing sufficient radiotherapy treatment planning. Target volume coverage was easily obtained using a combination of hemithorax irradiation and a sequential boost by an intensity-modulated-radiotherapy technique. In difficult individual treatment situations, surgical transpositions as well as organ autotransplantation might be useful in reducing radiotherapy organ dose levels.


  • Weiterbildung zum Facharzt für Strahlentherapie in Deutschland

    by Tobias Bölling, Heinrich Seegenschmiedt, Robert Semrau, Claus Rödel

    A sufficient number of well-trained specialists in radiation oncology is needed for an adequate supply in radiation oncology. Therefore, the training in radiation oncology is of utmost importance. This requirement is faced with a growing lack of physicians in Germany. The aim of this study was to characterize the current situation of radiation oncology training in Germany and to work out proposals to avoid a lack of radiotherapists. In summer 2008, 233 questionnaires were sent out to potential trainers in radiation oncology in Germany. The questions included, among others, the individual training situation and problems in finding physicians. A second questionnaire was addressed to trainees in radiation oncology and contained, e.g., questions regarding satisfaction, motivation for the choice of radiation oncology, a previous work in another discipline, and future perspectives. Answers were obtained from 107 supervisor physicians of whom 84.1% had the permission to employ trainees in radiation oncology. The finding of new trainees provided large problems in 47.1%; 35.3% had few and 17.6% no problems. For specialists in radiation oncology, 47.2% reported large, 26.4% few and 26.4% no problems in finding candidates. 113 trainees answered the questionnaires. Almost half of them (46.9%) had previously worked in another discipline. The majority was quite (44.2%) or fully (46.0%) satisfied with their job, 84.1% stated good up to excellent future perspectives. The vast majority (88.5%) would decide for a training in radiation oncology again. Trainees in radiation oncology in Germany are satisfied with their training, see good future perspectives and would again decide to do their training in radiation oncology. However, there are large problems in finding candidates for open jobs. A positive promotion is recommended to face these problems.


    • 6 February 2009
      • Vol. 28, 3885-90

    Perioperative high-dose rate brachytherapy using a bendy applicator (flab): treatment results of 74 patients.

    by Tobias Bölling, Patrick Schüller, Bernd Distelmaier, Andreas Schuck, Iris Ernst, Georg Gosheger, Winfried Winkelmann, Uta Dirksen, Heribert Jürgens, Hans-Lars Kronholz, et al.

    Radiotherapy plays a pivotal role in tumor treatment. Brachytherapy as an additional radiation technique allows local dose increments in areas at high risk of local failure. Our past 15-year experience with tissue-equivalent bendy applicator brachytherapy at the University Hospital Münster, Germany was reviewed. A series of 74 consecutive patients who had mainly been treated for sarcomas with perioperative brachytherapy was analyzed with a focus on local relapse-free survival and side-effects. The 5-year local control rate was 73% in primary treatment situations with a significant influence of additional external irradiation, surgical margin depth and tumor entity. Late sequelae of combined modality treatment were observed in 40 patients (54%) and mainly concerned wound healing (n = 18, 24%). A high-risk collective, in view of local failure, showed adequate local control rates as well as acceptable late sequelae. Flab brachytherapy is a good treatment option to achieve local radiation dose increments in patients at high risk of local failure.


  • Late Effects of Thoracic Irradiation in Children

    by Tobias Bölling, Stefan Könemann, Iris Ernst, Normann Willich

    To summarize the literature regarding the late effects of radiotherapy to the thorax in childhood and adolescence with special emphasis on cardiac and pulmonary impairment. The literature was critically reviewed using the PubMed® database with the key words “late effects”, “late sequelae”, “child”, “childhood”, “adolescence”, “radiation”, “radiotherapy”, “thorax”, “lung”, “heart”, and “pulmonary”. 17 publications dealing with radiation-induced pulmonary and cardiac late sequelae in children could be identified and were analyzed in detail. 29 further publications with additional information were also included in the analysis. Pulmonary function impairment after mediastinal irradiation arose in one third of all pediatric patients, even when treatment was performed with normofractionated lower doses (15–25 Gy). Whole lung irradiation was regularly followed by pulmonary function impairment with differing rates in several reports. However, clinically symptomatic function impairment like dyspnea was less frequent. Irradiation of up to 25 Gy (single doses ≤ 2 Gy) to the heart showed little or no cardiac toxicity in analyses of irradiated children (median follow-up 1.3–14.3 years). Doses of > 25 Gy (single doses ≤ 2–3.3 Gy) led to several cardiac dysfunctions. However, new data from adults with longer follow-up may indicate threshold doses as low as 1 Gy. Impairment of skeletal growth, breast hypoplasia, and secondary malignancy were further potential late sequelae. Several retrospective reports described radiation-associated late sequelae in children. However, there is still a lack of sufficient data regarding the characterization of dose-volume effects. Zusammenfassung der Literatur bezüglich Spätfolgen nach Strahlentherapie am Thorax bei Kindern und Jugendlichen mit einem Schwerpunkt auf kardialen und pulmonalen Funktionseinschränkungen. Literaturzusammenstellung mittels der PubMed®-Datenbank mit den Suchbegriffen „late effects“, „late sequelae“, „child“, „childhood“, „adolescence“, „radiation“, „radiotherapy“, „thorax“, „lung“, „heart“ und „pulmonary“. 17 Publikationen mit Daten zu strahlentherapieinduzierten pulmonalen und kardialen Spätfolgen bei Kindern wurden identifiziert und detailliert analysiert. Weitere 29 Publikationen mit zusätzlichen Informationen wurden in die Analyse mit eingeschlossen. Pulmonale Funktionseinschränkungen nach mediastinaler Bestrahlung im Kindesalter traten bei einem Drittel aller Patienten auf, auch wenn die Behandlung normofraktioniert mit Dosen von 15–25 Gy durchgeführt wurde (Tabelle 1a). Eine Ganzlungenbestrahlung ging regelmäßig mit einer gewissen Einschränkung einher (Tabelle 1b). Symptomatische Funktionseinschränkungen wie Dyspnoe waren jedoch seltener. Eine Bestrahlung bis zu 25 Gy am Herzen (Einzeldosen ≤ 2 Gy) zeigte keine oder wenige kardiale Spätfolgen in den Analysen zur Bestrahlung im Kindesalter (mediane Nachbeobachtung 1,3–14,3 Jahre). Höhere Bestrahlungsdosen > 25 Gy (Einzeldosen ≤ 2–3,3 Gy) führten zu einigen kardialen Spätfolgen (Tabelle 2). Allerdings deuten neue Daten bei Erwachsenen auf Dosisschwellenwerte von 1 Gy hin. Wachstumsstörungen, Brusthypoplasien und Sekundärmalignome wurden ebenso beschrieben. Einige retrospektive Berichte beschreiben strahlentherapieassoziierte Spätfolgen im Kindesalter. Allerdings gibt es keine suffizienten Daten bezüglich der Charakterisierung von Dosis-Volumen-Effekten.


  • Pediatric Radiation Oncology in Germany: A Study of Availability and Application

    by T. Bölling, I. Ernst, S. Könemann, N. Willich

    Background: Radiotherapy plays a pivotal role in many multimodal therapy concepts in pediatric oncology. However, the absolute number of irradiated children is estimated to be quite low. The aim of this study was to evaluate the availability and application of pediatric radiation oncology in Germany. Method: In summer 2007, a standardized questionnaire was sent to all radiotherapy facilities in Germany. The questions regarded the structure of the departments, the number of irradiated children each year including the distribution of the different diagnoses, the number of curative treatments, inclusion in study trials, and existence of special contact persons for pediatric radiotherapy as well as technical aspects of irradiation of children. Results: Answers to the questionnaires were obtained from 171 departments (77.4%). Of these, 67 (39%) stated to regularly treat children. These departments treated one to nine children in median each year (Conclusions: Due to quite low patient numbers treated in most radiotherapy facilities, individual experiences in pediatric radiation oncology can be assumed to be quite limited. As radiotherapy is part of multimodal therapy approaches in pediatric oncology and children treated with radiotherapy are at special risk for potential side effects, pediatric radiation oncology remains a sophisticated area. Therefore radiotherapy reference-institutions implemented by the therapy optimizing protocols are of fundamental importance. Hintergrund: Die Strahlentherapie ist ein elementarer Bestandteil vieler multimodaler Therapiekonzepte in der pädiatrischen Onkologie. Die Anzahl der dabei jährlich bestrahlten Kinder wird jedoch als recht gering eingeschätzt. Ziel dieser Untersuchung war es, die Versorgungsstrukturen der pädiatrischen Radioonkologie in Deutschland zu evaluieren. Methode: Im Sommer 2007 wurde ein standardisierter Fragebogen an alle Strahlentherapien in Deutschland versendet. Abgefragt wurden Art des Zentrums, Anzahl der jährlich behandelten Kinder inkl. Verteilung auf die einzelnen Erkrankungen, Anteil an kurativen Behandlungen und Teilnahme an Studien, Vorliegen eines speziellen Ansprechpartners sowie technische Aspekte bei Bestrahlungen im Kindesalter. Ergebnisse: Von 221 angeschriebenen Strahlentherapien haben sich 171 (77,4%) beteiligt, wobei 67 von diesen 171 Strahlentherapien (39%) Kinder strahlentherapeutisch behandelten. 44 Abteilungen hatten eine(n) eigene(n) Ansprechpartner(in) für pädiatrische Radioonkologie. Weniger als 5 behandelte Kinder pro Jahr gaben 23 Strahlentherapien an, 20 oder mehr Kinder pro Jahr wurden in 15 Abteilungen behandelt. Der Median lag bei 1-9 Kindern pro Jahr. Die meisten Behandlungen erfolgten bei Hirntumoren, Morbus Hodgkin und akuter lymphatischer Leukämie (ALL). Ein Großteil der Kinder wurde mit 3-D-konformalen Techniken bestrahlt, Sondertechniken wie intensitätsmodulierte Radiotherapie (IMRT) oder Brachytherapie wurden nur selten angegeben. Schlussfolgerung: Aufgrund recht geringer Patientenzahlen in den einzelnen Strahlentherapie-Einrichtungen muss angenommen werden, dass individuelle Erfahrungen in der pädiatrischen Onkologie limitiert sein können. Da jedoch die pädiatrische Radioonkologie Teil multimodaler Therapiekonzepte ist und die Strahlentherapie bei Kindern besondere Risiken im Hinblick auf Spätfolgen hat, bleibt die pädiatrische Radioonkologie ein anspruchsvolles Gebiet. Daraus ergibt sich die große Bedeutung der durch die Therapieoptimierungsstudien implementierten Referenz-Strahlentherapien.


  • Open Access

    Study protocol of the German "Registry for the Detection of Late Sequelae after Radiotherapy in Childhood and Adolescence" (RiSK)

    by Tobias Bolling, Andreas Schuck, Hildegard Pape, Christian Rube, Barbara Pollinger, Beate Timmermann, Rolf D Kortmann, Karin Dieckmann, Normann Willich

    Background: Late effects after radiotherapy in childhood and adolescence have mainly been characterized retrospectively with small patient numbers. However, these analyses are limited due to little information regarding organ dose levels in many cases. To overcome this limitation, the German Group of Paediatric Radiation Oncology (APRO) established the „Registry for the evaluation of late side effects after radiation in childhood and adolescence” (RiSK). The study protocol and the documentation forms are given in this publication. Methods/Design: Radiation parameters including detailed organ doses as well as toxicity evaluations are collected prospectively from centres all over Germany. Standardized documentation forms are used. These forms are given in an English and German version as additional files to this publication. Documentation is planned for all children who receive radiotherapy in one of the therapy trials of the "German Society of Paediatric Oncology and Haematology (GPOH)". The study started in a pilot phase in June 2001 in few centres. Since 2004 documentation has been performed all over Germany and is still on-going. Discussion: To our knowledge, "RiSK" is the only multi-centre study that evaluates radiation associated side effects prospectively with detailed information about organ dose levels. With ongoing recruitment and prolongation of follow-up powerful data will be obtained in a few years. A broad use and international cooperation are welcome.


  • Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors

    by Tobias Bölling, Andreas Schuck, Michael Paulussen, Uta Dirksen, Andreas Ranft, Stefan Könemann, Jürgen Dunst, Normann Willich, Heribert Jürgens

    Background: In the European Intergroup Cooperative Ewing's Sarcoma Study (EICESS) 92, whole lung irradiation (WLI) was performed in patients with primary lung metastases. This retrospective analysis evaluates the pulmonary function and the outcome of patients with exclusively pulmonary metastases. Patients and Methods: Between 1990 and 1999, 99 patients were registered into the EICESS-92-study trial with exclusively pulmonary metastases of Ewing tumors. The multimodal treatment regimen included polychemotherapy and local therapy to the primary tumor. WLI was performed with a dose between 12–21 Gy. 70 patients were treated with WLI, 13 of them received a further boost to their primary tumor in the thorax up to a cumulative dose of 54 Gy. Results: Pulmonary function tests were available for 37 patients treated with WLI (± boost). None, mild, moderate or severe pulmonary complications were seen in 43%, 29%, 21% and 7% of patients treated with WLI without further boost (median follow-up 25.2 months). Patients with an additional radiation boost or surgery to the thorax showed slightly higher rates of complications. Overall survival (OAS) showed a trend towards better results for patients with WLI (5-year-OAS: 0.61 for WLI vs. 0.49 for no WLI, p = 0.36). Conclusion: These data indicate a benefit and acceptable toxicity for WLI in the presented collective of patients. As long as there is no randomized prospective analysis, the present data confirm the indication for WLI in Ewing tumor patients with primary exclusively lung metastases.


  • Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy

    by Tobias Bölling, Christos Moustakis, Hassan Elsayed, Stefan-Bodo Müller, Christoph Weining, Gabriele Reinartz, Iris Ernst, Normann Willich, Stefan Könemann